Merck said adjusted earnings for the three months ending in December were pegged at $1.32, up 13.7% from the same period last year but 6 cents shy of the Street consensus forecast. Group revenues, Merck said, rose 5% to $12.5 billion but again missed analysts' estimates of a $12.68 billion tally.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,